Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

2816. Wick MR, Berg LC, Hertz MI (1992).
Large cell carcinoma of the lung with neuroendocrine
differentiation. A comparison
with large cell “undifferentiated” pulmonary
tumors. Am J Clin Pathol 97: 796-
805.
2817. Wick MR, Brown BA, Young RH, Mills
SE (1988). Spindle-cell proliferations of the
urinary tract. An immunohistochemical
study. Am J Surg Pathol 12: 379-389.
2818. Wick MR, Cherwitz DL, Manivel JC,
Sibley R (1990). Immunohistochemical findings
in tumors of the kidney. In: Tumor and
Tumor-like Conditions of the Kidneys and
Ureters, JN Eble, ed. Churchill Livingstone:
New York, pp. 207-247.
2819. Wick MR, Mills SE, Scheithauer BW,
Cooper PH, Davitz MA, Parkinson K (1986).
Reassessment of malignant “angioendotheliomatosis”.
Evidence in favor of its
reclassification as “intravascular lymphomatosis”.
Am J Surg Pathol 10: 112-
123.
2820. Wiener JS, Coppes MJ, Ritchey ML
(1998). Current concepts in the biology and
management of Wilms tumor. J Urol 159:
1316-1325.
2821. Wiener JS, Liu ET, Walther PJ (1992).
Oncogenic human papillomavirus type 16 is
associated with squamous cell cancer of
the male urethra. Cancer Res 52: 5018-5023.
2822. Wiener JS, Walther PJ (1994). A high
association of oncogenic human papillomaviruses
with carcinomas of the female
urethra: polymerase chain reaction-based
analysis of multiple histological types. J
Urol 151: 49-53.
2823. Wilcox G, Soh S, Chakraborty S,
Scardino PT, Wheeler TM (1998). Patterns
of high-grade prostatic intraepithelial neoplasia
associated with clinically aggressive
prostate cancer. Hum Pathol 29: 1119-1123.
2824. Wiley EL, Davidson P, McIntire DD,
Sagalowsky AI (1997). Risk of concurrent
prostate cancer in cystoprostatectomy
specimens is related to volume of highgrade
prostatic intraepithelial neoplasia.
Urology 49: 692-696.
2825. Wilkins BS, Williamson JM, O’Brien
CJ (1989). Morphological and immunohistological
study of testicular lymphomas.
Histopathology 15: 147-156.
2826. Williams JC, Merguerian PA, Schned
AR, Amdur RJ (1994). Bilateral testicular
carcinoma in situ in persistent mullerian
duct syndrome: a case report and literature
review. Urology 44: 595-598.
2827. Williams SG, Buscarini M, Stein JP
(2001). Molecular markers for diagnosis,
staging, and prognosis of bladder cancer.
Oncology (Huntingt) 15: 1461-1476.
2828. Williams TR, Wagner BJ, Corse WR,
Vestevich JC (2002). Fibroepithelial polyps
of the urinary tract. Abdom Imaging 27:
217-221.
2829. Willis TG, Jadayel DM, Du MQ, Peng
H, Perry AR, Abdul-Rauf M, Price H, Karran
L, Majekodunmi O, Wlodarska I, Pan L,
Crook T, Hamoudi R, Isaacson PG, Dyer MJ
(1999). Bcl10 is involved in t(1;14)(p22;q32)
of MALT B cell lymphoma and mutated in
multiple tumor types. Cell 96: 35-45.
2830. Wills ML, Hamper UM, Partin AW,
Epstein JI (1997). Incidence of high-grade
prostatic intraepithelial neoplasia in sextant
needle biopsy specimens. Urology 49:
367-373.
2831. Wilson BE, Netzloff ML (1983).
Primary testicular abnormalities causing
precocious puberty Leydig cell tumor,
Leydig cell hyperplasia, and adrenal rest
tumor. Ann Clin Lab Sci 13: 315-320.
2832. Wilson TG, Pritchett TR, Lieskovsky
G, Warner NE, Skinner DG (1991). Primary
adenocarcinoma of bladder. Urology 38:
223-226.
2833. Wirnsberger GH, Ratschek M, Dimai
HP, Holzer H, Mandal AK (1999). Posttransplantation
lymphoproliferative disorder
of the T-cell/B-cell type: an unusual
manifestation in a renal allograft. Oncol
Rep 6: 29-32.
2834. Wishnow KI, Johnson DE, Swanson
DA, Tenney DM, Babaian RJ, Dunphy CH,
Ayala AG, Ro JY, von Eschenbach AC
(1989). Identifying patients with low-risk
clinical stage I nonseminomatous testicular
tumors who should be treated by surveillance.
Urology 34: 339-343.
2835. Witjes JA, Kiemeney LA, Schaafsma
HE, Debruyn FM (1994). The influence of
review pathology on study outcome of a
randomized multicentre superficial bladder
cancer trial. Members of the Dutch
South East Cooperative Urological Group.
Br J Urol 73: 172-176.
2836. Wolf H, Olsen PR, Fischer A,
Hojgaard K (1987). Urothelial atypia concomitant
with primary bladder tumour.
Incidence in a consecutive series of 500
unselected patients. Scand J Urol Nephrol
21: 33-38.
2837. Wood DPJr, Montie JE, Pontes JE,
Vanderbrug Medendrop S, Levin HS (1989).
Transitional cell carcinoma of the prostate
in cystoprostatectomy specimens
removed for bladder cancer. J Urol 141:
346-349.
2838. Wood EW, Gardner WAJr, Brown FM
(1972). Spindle cell squamous carcinoma
of the penis. J Urol 107: 990-991.
2839. Woodruff JM, Godwin TA, Erlandson
RA, Susin M, Martini N (1981). Cellular
schwannoma: a variety of schwannoma
sometimes mistaken for a malignant tumor.
Am J Surg Pathol 5: 733-744.
2840. Woolcott CG, King WD, Marrett LD
(2002). Coffee and tea consumption and
cancers of the bladder, colon and rectum.
Eur J Cancer Prev 11: 137-145.
2841. World Cancer Research Fund in
Association with American Institute for
Cancer Research (1997). Food, Nutrition
and the Prevention of Cancer: A Global
Perspective. WCRF: Washington, DC.
2842. World Cancer Research Fund Panel
(1997). Diet, nutrition and the prevention of
cancer: a global perspective. WCRF:
Washington, DC.
2843. World Health Organization (2003).
World Health Statistics Annual 1997-1999
Edition. http://www.who.int/whosis.
2844. Wright C, Mellon K, Johnston P, Lane
DP, Harris AL, Horne CH, Neal DE (1991).
Expression of mutant p53, c-erbB-2 and the
epidermal growth factor receptor in transitional
cell carcinoma of the human urinary
bladder. Br J Cancer 63: 967-970.
2845. Wright C, Thomas D, Mellon K, Neal
DE, Horne CH (1995). Expression of
retinoblastoma gene product and p53 protein
in bladder carcinoma: correlation with
Ki67 index. Br J Urol 75: 173-179.
2846. Wright GL, Haley C, Beckett ML,
Schellhammer PF (1995). Expression of
prostate-specific membrane antigen in
normal, benign and malignant tissues. Urol
Oncol 1: 18-28.
2847. Wright GLJr, Grob BM, Haley C,
Grossman K, Newhall K, Petrylak D, Troyer
J, Konchuba A, Schellhammer PF, Moriarty
R (1996). Upregulation of prostate-specific
membrane antigen after androgen-deprivation
therapy. Urology 48: 326-334.
2848. Wu RL, Osman I, Wu XR, Lu ML,
Zhang ZF, Liang FX, Hamza R, Scher H,
Cordon-Cardo C, Sun TT (1998). Uroplakin II
gene is expressed in transitional cell carcinoma
but not in bilharzial bladder squamous
cell carcinoma: alternative pathways
of bladder epithelial differentiation and
tumor formation. Cancer Res 58: 1291-1297.
2849. Wu SQ, Hafez GR, Xing W, Newton M,
Chen XR, Messing E (1996). The correlation
between the loss of chromosome 14q with
histologic tumor grade, pathologic stage,
and outcome of patients with nonpapillary
renal cell carcinoma. Cancer 77: 1154-1160.
2850. Wu X, Senechal K, Neshat MS,
Whang YE, Sawyers CL (1998). The
PTEN/MMAC1 tumor suppressor phosphatase
functions as a negative regulator
of the phosphoinositide 3-kinase/Akt pathway.
Proc Natl Acad Sci USA 95: 15587-
15591.
2851. Wyatt JK, Craig I (1980). Verrucous
carcinoma of urinary bladder. Urology 16:
97-99.
2852. Xiao SY, Rizzo P, Carbone M (2000).
Benign papillary mesothelioma of the tunica
vaginalis testis. Arch Pathol Lab Med
124: 143-147.
2853. Xiaoxu L, Jianhong L, Jinfeng W,
Klotz LH (2001). Bladder adenocarcinoma:
31 reported cases. Can J Urol 8: 1380-1383.
2854. Xipell JM (1971). The incidence of
benign renal nodules (a clinicopathologic
study). J Urol 106: 503-506.
2855. Xu J, Meyers D, Freije D, Isaacs S,
Wiley K, Nusskern D, Ewing C, Wilkens E,
Bujnovszky P, Bova GS, Walsh P, Isaacs
W, Schleutker J, Matikainen M, Tammela
T, Visakorpi T, Kallioniemi OP, Berry R,
Schaid D, French A, McDonnell S,
Schroeder J, Blute M, Thibodeau S,
Gronberg H, Emanuelsson M, Damber JE,
Bergh A, Jonsson BA, Smith J, Bailey-
Wilson J, Carpten J, Stephan D, Gillanders
E, Amundson I, Kainu T, Freas-Lutz D,
Baffoe-Bonnie A, Van Aucken A, Sood R,
Collins F, Brownstein M, Trent J (1998).
Evidence for a prostate cancer susceptibility
locus on the X chromosome. Nat Genet
20: 175-179.
2856. Xu J, Stolk JA, Zhang X, Silva SJ,
Houghton RL, Matsumura M, Vedvick TS,
Leslie KB, Badaro R, Reed SG (2000).
Identification of differentially expressed
genes in human prostate cancer using
subtraction and microarray. Cancer Res
60: 1677-1682.
2857. Xu J, Zheng SL, Komiya A,
Mychaleckyj JC, Isaacs SD, Hu JJ, Sterling
D, Lange EM, Hawkins GA, Turner A, Ewing
CM, Faith DA, Johnson JR, Suzuki H,
Bujnovszky P, Wiley KE, de Marzo AM,
Bova GS, Chang B, Hall MC, McCullough
DL, Partin AW, Kassabian VS, Carpten JD,
Bailey-Wilson JE, Trent JM, Ohar J,
Bleecker ER, Walsh PC, Isaacs WB,
Meyers DA (2002). Germline mutations and
sequence variants of the macrophage
scavenger receptor 1 gene are associated
with prostate cancer risk. Nat Genet 32:
321-325.
2858. Xu J, Zheng SL, Turner A, Isaacs SD,
Wiley KE, Hawkins GA, Chang BL, Bleecker
ER, Walsh PC, Meyers DA, Isaacs WB
(2002). Associations between hOGG1
sequence variants and prostate cancer
susceptibility. Cancer Res 62: 2253-2257.
2859. Xu X, Stower MJ, Reid IN, Garner RC,
Burns PA (1996). Molecular screening of
multifocal transitional cell carcinoma of
the bladder using p53 mutations as biomarkers.
Clin Cancer Res 2: 1795-1800.
2860. Yachia D, Auslaender L (1989).
Primary leiomyosarcoma of the testis. J
Urol 141: 955-956.
2861. Yagi H, Igawa M, Shiina H, Shigeno K,
Yoneda T, Wada Y, Urakami S (1999).
Inverted papilloma of the urinary bladder in
a girl. Urol Int 63: 258-260.
2862. Yalla SV, Ivker M, Burros HM, Dorey F
(1975). Cystitis glandularis with perivesical
lipomatosis. Frequent association of two
unusual proliferative conditions. Urology 5:
383-386.
2863. Yamamoto T, Ito K, Suzuki K,
Yamanaka H, Ebihara K, Sasaki A (2002).
Rapidly progressive malignant epithelioid
angiomyolipoma of the kidney. J Urol 168:
190-191.
2864. Yaman O, Baltaci S, Arikan N, Yilmaz
E, Gogus O (1996). Staging with computed
tomography, transrectal ultrasonography
and transurethral resection of bladder
tumour: comparison with final pathological
stage in invasive bladder carcinoma. Br J
Urol 78: 197-200.
2865. Yang CH, Krzyzaniak K, Brown WJ,
Kurtz SM (1985). Primary carcinoid tumor of
urinary bladder. Urology 26: 594-597.
2866. Yang CW, Park JH, Park JH, Cho SG,
Kim YS, Bang BK (2001). Acute graft dysfunction
due to Kaposi sarcoma involving
the bladder in a renal transplant recipient.
Nephrol Dial Transplant 16: 625-627.
2867. Yang RM, Naitoh J, Murphy M, Wang
HJ, Phillipson J, Dekernion JB, Loda M,
Reiter RE (1998). Low p27 expression predicts
poor disease-free survival in patients
with prostate cancer. J Urol 159: 941-945.
2868. Yang XJ, McEntee M, Epstein JI
(1998). Distinction of basaloid carcinoma of
the prostate from benign basal cell lesions
by using immunohistochemistry for bcl-2
and Ki-67. Hum Pathol 29: 1447-1450.
2869. Yang XJ, Wu CL, Woda BA, Dresser K,
Tretiakova M, Fanger GR, Jiang Z (2002).
Expression of alpha-Methylacyl-CoA racemase
(P504S) in atypical adenomatous
hyperplasia of the prostate. Am J Surg
Pathol 26: 921-925.
2870. Yashi M, Hashimoto S, Muraishi O,
Tozuka K, Tokue A (2000). Leiomyoma of the
ureter. Urol Int 64: 40-42.
2871. Yashi M, Muraishi O, Kobayashi Y,
Tokue A, Nanjo H (2002). Elevated serum
progastrin-releasing peptide (31-98) in
metastatic and androgen-independent
prostate cancer patients. Prostate 51: 84-
97.
2872. Yasukawa S, Aoshi H, Takamatsu M
(1987). Ectopic prostatic adenoma in retrovesical
space. J Urol 137: 998-999.
2873. Yasunaga Y, Shin M, Fujita MQ,
Nonomura N, Miki T, Okuyama A, Aozasa K
(1998). Different patterns of p53 mutations in
prostatic intraepithelial neoplasia and concurrent
carcinoma: analysis of microdissected
specimens. Lab Invest 78: 1275-1279.
2874. Yatani R, Chigusa I, Akazaki K,
Stemmermann GN, Welsh RA, Correa P
(1982). Geographic pathology of latent prostatic
carcinoma. Int J Cancer 29: 611-616.
2875. Yazaki T, Takahashi S, Ogawa Y,
Kanoh S, Kitagawa R (1985). Large renal
hemangioma necessitating nephrectomy.
Urology 25: 302-304.
2876. Ylagan LR, Humphrey PA (2001).
Micropapillary variant of transitional cell
carcinoma of the urinary bladder: a report
of three cases with cytologic diagnosis in
urine specimens. Acta Cytol 45: 599-604.
2877. Yong EL, Lim J, Qi W, Ong V, Mifsud A
(2000). Molecular basis of androgen receptor
diseases. Ann Med 32: 15-22.
350 References